MicroRNA 3153 (MIR3153)

MicroRNA 3153 (MIR3153) is a putative human microRNA, a member of the non-coding RNA family responsible for post-transcriptional regulation of gene expression in eukaryotic cells[3][2]. MicroRNAs generally act by binding to complementary sequences in messenger RNA (mRNA), inhibiting translation or leading to target degradation[3][2]. However, there is no widely available evidence or peer-reviewed literature specifically characterizing the biological function, disease roles, or clinical relevance of MIR3153. Major reviews and microRNA databases do not report validated targets, disease associations, or therapeutic activities for microRNA 3153.\n\nKey context and details: \n- MIR3153 is classified as a microRNA, which are single-stranded, ~22nt non-coding RNAs involved in post-transcriptional gene regulation[3][2]. \n- There is no record of MIR3153 being a therapeutic target, biomarker, or having any validated disease association in the peer-reviewed literature or publicly available molecular databases as of September 2025. \n- Most microRNAs act by silencing target gene expression, and some can be linked to specific cellular functions or diseases, but MIR3153 is not included among the functionally characterized miRNAs in studies of prominent disease processes, such as breast cancer or cancer stem cell biology[1][4]. \n- No drugs, mechanisms of action, safety concerns, or biomarkers specific to MIR3153 are reported in the accessible literature. \n- There is no indication that the term "MIR3153" is misspelled; it matches the naming convention for human microRNAs (hsa-mir-3153). However, the lack of functional, clinical, or pharmacological data suggests that MIR3153 is not currently a relevant drug target.\n\nIf more targeted information on MIR3153 arises in future studies or database releases, it may become possible to attribute biological or therapeutic functions. As of the provided resources, it should not be considered a validated therapeutic target.

Other names

hsa-mir-3153mir-3153MIR3153